Clonal evoluation and lung cancer pharmacogenomics
Background: Lung cancer is the world's leading cause of cancer death, with a 5 year survival rate of ~16%. Several factors contribute to this poor prognosis: the limited detection of disease at treatable stages, the high metastatic potential of any primary tumour, and the variable effectiveness...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
University of British Columbia
2009
|
| Online Access: | http://hdl.handle.net/2429/9532 |